Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-714-0 | CAS number: 1474044-77-3
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 22.3 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 675 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- assuming 100% absorption via oral and 10% via inhalative route the NOAEL of 95 mg/kg bw/d from a subacute study is corrected by multiplying with 100/10 and division by 0.38 m3/kg for air consumption and multiplication with 6.7/10 for light work adjustment --> NOAECcorr = 95 mg/kg bw/d * 100/10 * 6.7/10 / 0.38 m3/kg/d = 1675 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- NOAEC used as starting point
- AF for differences in duration of exposure:
- 6
- Justification:
- based on the subacute study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- not required due to route-to-route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- default factor for remaining differences
- AF for intraspecies differences:
- 5
- Justification:
- for worker, a default AF of 5 is to be used
- AF for the quality of the whole database:
- 1
- Justification:
- not required
- AF for remaining uncertainties:
- 1
- Justification:
- not required
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 950 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- oral to dermal, assuming 100% oral absorption and 10% dermal absorption and thereby corrected by multiplying with 100/10
- AF for dose response relationship:
- 1
- Justification:
- NOAEL is used as the starting point
- AF for differences in duration of exposure:
- 6
- Justification:
- based on the subacute study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rats are used in the animal test
- AF for other interspecies differences:
- 2.5
- Justification:
- no other substance-specific information is available
- AF for intraspecies differences:
- 5
- Justification:
- default factor for worker
- AF for the quality of the whole database:
- 1
- Justification:
- Available data from substance fulfilling scientific principle is used
- AF for remaining uncertainties:
- 1
- Justification:
- no other uncertainties needed to be considered.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.2 mg/kg bw/day
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
Due to low vapor pressure (3.3E-5 Pa at 20 °C) and high boiling point (> 50 °C), the inhalation route is not considered to be a relevant exposure route to human. However, an inhalative DNEL, long-term systemic has been derived.
It is assumed in the Toxicokinetik assessment based ona conservative approach that the absorption rate from dermal and inhalative route is considered to be 10% whereas by oral route 100% absorption is assumed. Thus the NOAEL inhalative and dermal, derived by route to route extrapolation, have been adjusted accordingly.
One GLP study following OECD guideline 422 was conducted to investigate the potential toxicity of DNNSA and identified NOAEL:
Parental NOAEL: 95 mg/kg/day
Reproduction NOAEL: at least 893 mg/kg/day
Developmental NOAEL: 298 mg/kg body weight/day.
In this study, treatment of male and female Wistar rats with di C8-C10, branched, C9 rich, alkylnaphthalene sulphonic acid (DNNSA) by oral gavage at dose levels of 95, 298, 893 mg/kg body weight/day revealed parental toxicity at 298 and 893 mg/kg body weight/day. At 95 mg/kg, no toxicologically relevant effects were noted in any of the parameters. Developmental toxicity (lower pup body weights) was observed at the high dose of 893 mg/kg. No developmental toxicity was observed for treatments of 95 and 298 mg/kg body weight/day. The NOAEL was 298 mg/kg body weight/day.No reproduction toxicity was observed for treatment up to 893 mg/kg body weight/day.
Therefore, the NOAEL of 95 mg/kg/day was selected as the basis for DNEL derivation according to the strict rule.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 826 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- assuming 100% absorption via oral and 10% via inhalative route the NOAEL of 95 mg/kg bw/d from a subacute study is corrected by multiplying with 100/10 and by division by 1.15 m3/kg/d for air consumption --> NOAECcorr = 95 mg/kg bw/d * 100/10 / 1.15 m3/kg/d = 826 mg/m3.
- AF for dose response relationship:
- 1
- Justification:
- not required, starting point is NOAEC
- AF for differences in duration of exposure:
- 6
- Justification:
- based on the subacute study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- not required due to route-to-route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- default factor for remaining differences
- AF for intraspecies differences:
- 10
- Justification:
- for general population, a default AF of 10 is to be used
- AF for the quality of the whole database:
- 1
- Justification:
- not required
- AF for remaining uncertainties:
- 1
- Justification:
- not required
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.6 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 950 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- oral to dermal
- AF for dose response relationship:
- 1
- Justification:
- NOAEL is used as the starting point
- AF for differences in duration of exposure:
- 6
- Justification:
- based on the subacute study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rats are used in the animal test
- AF for other interspecies differences:
- 2.5
- Justification:
- no other substance-specific data are available.
- AF for intraspecies differences:
- 10
- Justification:
- for general population, a default factor of 10 is used.
- AF for the quality of the whole database:
- 1
- Justification:
- available data from substance fulfill the scientific principles
- AF for remaining uncertainties:
- 1
- Justification:
- no other uncertainties need to be considered
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.6 mg/kg bw/day
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.16 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 95 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- no route to route
- AF for dose response relationship:
- 1
- Justification:
- NOAEL is used as the starting point
- AF for differences in duration of exposure:
- 6
- Justification:
- based on a subacute study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rats are used in the animal test
- AF for other interspecies differences:
- 2.5
- Justification:
- no other substance-specific information are available
- AF for intraspecies differences:
- 10
- Justification:
- default factor for general population
- AF for the quality of the whole database:
- 1
- Justification:
- available data from substance fulfill scientific principle is used
- AF for remaining uncertainties:
- 1
- Justification:
- no other uncertainties needed to be considered.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.16 mg/kg bw/day
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - General Population
Due to low vapor pressure (3.3E-5 Pa at 20 °C) and high boiling point (> 50 °C), the inhalation route is not considered to be a relevant exposure route to human. However, an inhalative DNEL for systemic long-term toxicity was derived.
It is assumed in the Toxicokinetik assessment based ona conservative approach that the absorption rate from dermal and inhalative route is considered to be 10% whereas by oral route 100% absorption is assumed. Thus the NOAEL inhalative and dermal, derived by route to route extrapolation, have been adjusted accordingly.
One GLP study following OECD guideline 422 was conducted to investigate the potential toxicity of DNNSA and identified NOAEL:
Parental NOAEL: 95 mg/kg/day
Reproduction NOAEL: at least 893 mg/kg/day
Developmental NOAEL: 298 mg/kg body weight/day.
In this study, treatment of male and female Wistar rats with di C8-C10, branched, C9 rich, alkylnaphthalene sulphonic acid (DNNSA) by oral gavage at dose levels of 95, 298, 893 mg/kg body weight/day revealed parental toxicity at 298 and 893 mg/kg body weight/day. At 95 mg/kg, no toxicologically relevant effects were noted in any of the parameters. Developmental toxicity (lower pup body weights) was observed at the high dose of 893 mg/kg. No developmental toxicity was observed for treatments of 95 and 298 mg/kg body weight/day. The NOAEL was 298 mg/kg body weight/day.No reproduction toxicity was observed for treatment up to 893 mg/kg body weight/day.
Therefore, the NOAEL of 95 mg/kg/day was selected as the basis for DNEL derivation according to the strict rule.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
